Atezolizumab (Tecentriq) in combination with nab-paclitaxel



I work in the Policy and Campaigns Team at Breast Cancer Now and I wanted to ask if anyone has taken the drug atezolizumab (also known as Tecentriq) in combination with nab-paclitaxel for untreated, locally advanced or metastatic triple negative breast cancer?


You could help shape our input to the National Institute of Health and Care Excellence (NICE) consultation on the draft guidance issued for this treatment which has provisionally not recommended this treatment option for use on the NHS.


We want to hear from people that have received this treatment to help shape our response to the consultation which will then inform the final decision on the use of this treatment.


If you can help, please get in touch and tell us your story by 21 October


If you have any questions about our work in this area, please email


Thanks for your help,